Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Fat Prophets
Fat Prophets's columns :
12/14/2006Carlco
12/07/2006Avocet Mining
12/01/2006JP Morgan Indian Investment Trust
11/23/2006ICI
11/15/2006Friends Provident
10/26/2006Royal & SunAlliance
10/12/2006Dragon Oil
09/15/2006BT Group
09/08/2006Friends Provident
08/21/2006Anglo American
08/02/2006Dragon Oil
07/24/2006Aviva >>
06/23/2006JKX Oil & Gas
05/30/2006GlaxoSmithKline
05/10/2006Peter Hambro Mining
04/20/2006Dana Petroleum
04/10/2006Amec PLC
03/23/2006Golden Prospect
03/09/2006British Petroleum

« EARLIEST ‹ PrevNext › LATEST »
Fat Prophets – Dog of the Week

Dog Of The Week - a weekly column from Fat Prophets, the providers of independent, unbiased research. Each stock is rated as either a Labrador, Poodle, Greyhound or Border Collie. All of the dogs have their own unique characteristics and qualities. Check out the 'Pound' on the left for an explanation of each dog.


Aviva

07/24/2006

The UK's largest insurance services provider, Aviva (AV) announced last week plans to acquire AmerUs Group for £1.6 billion in cash. The purchase will immediately transform operations in America providing Aviva with a significant position in a high growth segment of the world's largest savings market.

AmerUs offers a range of protection and accumulation products, however equity-indexed products have been the focus over the last few years. These products typically offer minimum guaranteed benefits with the potential for higher returns based on the performance of an underlying index.

Growth in these products has been impressive and AmerUs has an enviable market share. AmerUs' three year compounded annual growth rate (CAGR) to 2005 in both equity annuity deposits and protection sales has been 35 percent. As such, we believe Aviva's choice of acquisition target is a wise one.

Aviva's purchase price of US$69 a share represents a 10 percent premium to AmerUs' closing price the day before confirmation talks between the two were taking place. Despite the premium, we believe the offer price is fair.

Besides America, Aviva is also expanding in other exciting markets. In March of this year, the company received a license to operate in Russia. Whilst in China, the company received regulatory approval for the joint venture, Aviva-COFCO, to operate in the city of Jinan. The JV now has licences to operate in 12 cities.

All of this activity has overshadowed the outstanding performance Aviva has thus far put in this year. In a recent trading update, Aviva said that first half pre-tax profits surged ahead 43 percent to £1.35 billion. The group's new business sales growth has continued in the second quarter where the first ended, up 20 percent.

General insurance also performed well. The segment's combined operating ratio (COR), a key measure of profitability, in the first half of the year was around 93 percent. This figure is well below Aviva's target of 98 percent, although by year-end the COR is expected to worsen slightly to 95 percent.

Aviva currently trades on an undemanding prospective price earnings multiple of nearly 9 times while yielding 4 percent. In our opinion, the growth prospects offered by last week's announcement along with initiatives in China, Russia and India bode well for future earnings out-performance in the years ahead.


Fat Prophets is the trading name for Mint Financial (UK) limited, (Company Number 04255908). Mint Financial (UK) Limited is authorised and regulated by the Financial Services Authority (Firm Reference Number 220591).

To view a recent stockmarket report from Fat Prophets click here